Sermorelin / GHRP-2 stack: what's in it
- 2 sources
- How we source
- We don't sell peptides. We never link "research use only" sellers.
The short answer
Sermorelin / GHRP-2 stack combines Sermorelin and GHRP-2.
What it is
GH-axis stack.
What people look into
Muscle and exercise, aging, sleep
Results for one compound don't tell you what the two do together.
The parts
FDA-approved, discontinued
WADA 2026: S2.2.4
Sermorelin Papers on animals 107 Lab-dish (cell) papers 26 Papers PubMed tags as about people 76 Registered trials (ClinicalTrials.gov) 0 of 27 search results name Sermorelin Randomized trials in people 3 Not FDA-approved
WADA 2026: S2.2.4
Bars are counts of papers or trials; a longer bar means more studies, not better results. Study counts auto-counted from PubMed tags and ClinicalTrials.gov in the Ellum research database, as of October 6, 2026 (not reviewed; a paper can carry more than one tag). Papers PubMed tags as about people: includes reviews and case reports; not randomized trials. All bars share one scale. Each count is for that part alone.
Regulatory status by component
Not FDA-approved How we label status
- As of October 4, 2026, no FDA-approved Sermorelin product for human use is sold in the US. FDA approved Geref for human use in 1990; it has been discontinued. See Sermorelin in the Index →
- As of October 4, 2026, GHRP-2 (pralmorelin) is not FDA-approved for any use and is not on FDA's 503A bulks list. See GHRP-2 (pralmorelin) in the Index →
Status as of October 4, 2026
- As a combination
- No category as a combination (see components)
Get updates on Sermorelin / GHRP-2 stack
The research on Sermorelin / GHRP-2 stack
Key facts
Also known as: sermorelin ghrp-2
- Parts
- Sermorelin and GHRP-2 (pralmorelin)
- Route
- injectable;nasal
References
Status sources
Sources as of October 4, 2026
What this doesn’t establish
Results for one compound don't tell you what the two do together.